Lunai Bioworks (LNAI) Intangibles (2012 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Intangibles of $119115.0 in Q1 2026, down 16.17% quarter-over-quarter from $142096.0 in Q4 2025, and up 636.55% on a YoY basis from $16172.0 in Q1 2025.
Lunai Bioworks (LNAI) Intangibles (2012 - 2026) Analysis & Trends
Lunai Bioworks' Intangibles history runs 15 years deep, the most recent figure standing at $119115.0 for Q1 2026.
- In Q1 2026, Intangibles rose 636.55% year-over-year to $119115.0; the TTM figure through Mar 2026 stood at $119115.0 (up 636.55% YoY), while the FY2025 annual figure was $6.0 million, down 96.26% from the prior year.
- Intangibles was $119115.0 for Q1 2026 at Lunai Bioworks, down from $142096.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $174.9 million in Q1 2024 to a low of $16172.0 in Q1 2025.
- Historically, Intangibles has averaged $44.8 million across 5 years, with a median of $30.1 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Intangibles soared 121591.44% in 2023, then slumped 99.99% in 2025.
- A 5-year view of Intangibles shows it stood at $73.2 million in 2022, then slipped by 25.9% to $54.3 million in 2023, then plunged by 99.97% to $17853.0 in 2024, then surged by 695.92% to $142096.0 in 2025, then decreased by 16.17% to $119115.0 in 2026.
- The last three Intangibles figures came in at $119115.0 (Q1 2026), $142096.0 (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 119,115.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119,115.00 |
| Dec 31, 2025 | 142,096.00 |
| Sep 30, 2025 | 5.96 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 16,172.00 |
| Dec 31, 2024 | 17,853.00 |
| Sep 30, 2024 | 28,750.00 |
| Jun 30, 2024 | 159.33 Mn |
| Mar 31, 2024 | 174.94 Mn |
| Dec 31, 2023 | 54.25 Mn |
| Sep 30, 2023 | 54.25 Mn |
| Jun 30, 2023 | 54.25 Mn |
| Mar 31, 2023 | 61.57 Mn |
| Sep 30, 2022 | 73.21 Mn |
| Jun 30, 2022 | 73.21 Mn |
| Mar 31, 2022 | 50,596.00 |
| Dec 31, 2021 | 154.82 Mn |
| Sep 30, 2021 | 60,537.00 |
| Jun 30, 2021 | 65,906.00 |
| Mar 31, 2021 | 69,225.00 |